BRIEF published on 06/10/2026 at 07:35, 21 days 23 hours ago Sensorion Advances SENS-601 for GJB2-Related Hearing Loss Clinical Trials Gene Therapy Sensorion SENS-601 GJB2 Hearing Loss
BRIEF published on 06/10/2026 at 07:35, 21 days 23 hours ago Sensorion Refocuses on SENS-601 for Gene Therapy Clinical Trials Gene Therapy Sensorion Hearing Loss SENS-601
PRESS RELEASE published on 06/10/2026 at 07:30, 21 days 23 hours ago Inside Information / Other news releases Sensorion achieves key regulatory milestones for SENS-601 addressing GJB2-related hearing loss and discontinues SENS-501. Fast Track procedure granted by ANSM in France. Clinical trials planned in Canada and U.S. IND submission targeted by 2026 Clinical Trials Gene Therapy Sensorion Regulatory Milestones GJB2-related Hearing Loss
BRIEF published on 05/18/2026 at 07:35, 1 month 14 days ago Fred Chereau appointed Managing Director of Sensorion Gene Therapy General Management Hearing Loss Sensory Fred Chereau
BRIEF published on 05/18/2026 at 07:35, 1 month 14 days ago Sensorion Appoints Fred Chereau as CEO Biotechnology CEO Appointment Gene Therapy Sensorion Fred Chereau
PRESS RELEASE published on 05/18/2026 at 07:30, 1 month 14 days ago Inside Information / Other news releases Sensorion appoints Fred Chereau as Chief Executive Officer, bringing extensive leadership experience in gene therapy and rare diseases. Amit Munshi continues as Chairman of the Board Gene Therapy Chief Executive Officer Rare Diseases Sensorion Fred Chereau
BRIEF published on 05/13/2026 at 07:35, 1 month 19 days ago Results of the Sensorion General Meeting Biotechnology General Assembly Resolutions Adopted Hearing Loss Sensory
PRESS RELEASE published on 05/13/2026 at 07:30, 1 month 19 days ago Inside Information / Other news releases Sensorion releases results of Combined General Meeting resolutions. All recommended resolutions adopted with 77.83% capital presence. Details available on website Shareholders General Meeting Resolutions Sensorion Hearing Loss
BRIEF published on 05/05/2026 at 07:35, 1 month 27 days ago Sensorion is participating in the ASGCT annual conference Gene Therapy Hearing Loss SENS-601 Sensory ASGCT 2026
BRIEF published on 05/05/2026 at 07:35, 1 month 27 days ago Sensorion Participates in ASGCT Annual Meeting Biotechnology Gene Therapy Sensorion Hearing Loss ASGCT 2026
Published on 07/01/2026 at 17:00, 14 hours 11 minutes ago Notification of Relevant Change to Significant Shareholder
Published on 07/01/2026 at 14:30, 16 hours 41 minutes ago AIAI Holdings' MediGuide Launches Digital Platform
Published on 07/01/2026 at 13:30, 17 hours 41 minutes ago Sidney Resources Corporation Appoints Former Idaho Governor C.L. "Butch" Otter as Chairman of the Board
Published on 07/01/2026 at 13:00, 18 hours 11 minutes ago Fox River Issues Shares Pursuant to Exploration Agreement in Connection with Impending Arrangement
Published on 07/01/2026 at 03:15, 1 day 3 hours ago GLG Life Tech Corporation Announces 2026 AGM Voting Results
Published on 07/02/2026 at 07:00, 11 minutes ago Trade Republic’s new trading technology: Best Price Execution across all relevant exchanges. Direct Price Order to select across 30 global exchanges. Advanced web terminal for active investors.
Published on 07/01/2026 at 20:40, 10 hours 31 minutes ago KNDS to resume its Initial Public Offering process when Capital Markets conditions are supportive
Published on 07/01/2026 at 20:04, 11 hours 7 minutes ago 2CRSi SA: 2CRSi initiates an independent verification procedure regarding its German contract.
Published on 07/01/2026 at 19:00, 12 hours 11 minutes ago OLB strengthens its leadership team to drive the next phase of growth
Published on 07/01/2026 at 18:55, 12 hours 16 minutes ago OLB Ensures Leadership Continuity Following Management Board Changes / Christophe Jéhan assumes responsibilities for Marc Ampaw’s business areas on interim basis
Published on 07/01/2026 at 18:26, 12 hours 45 minutes ago Modula renews its confidence in AMA with a four-year agreement integrating XpertEye’s new AI-powered features
Published on 07/01/2026 at 17:54, 13 hours 17 minutes ago TF1 - Monthly disclosure of the total number of shares and voting rights - June 2026
Published on 07/01/2026 at 17:45, 13 hours 26 minutes ago Availability of the Pre-H1 2026 Results Communication
Published on 07/01/2026 at 17:40, 13 hours 31 minutes ago Report on share repurchases from 24 to 30 June 2026
Published on 07/01/2026 at 17:35, 13 hours 36 minutes ago Disclosure of transactions in own shares from June 29 to June 30, 2026
